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ABSTRACT 
The human microbiome ecosystem plays numerous, yet poorly understood 
beneficial roles in human health. It can shape the immune response and provide essential 
vitamins and enzymes to the host. The different environments present in the human host 
are a major determinant of community composition. Conversely, the presence of certain 
bacteria in specific parts of the human body is sometimes associated with an increased 
chance of pathologies. Advances in DNA sequencing have increased our understanding 
of the relationship of microbes with the environment. However, sequencing data alone is 
unlikely to provide such understanding without the help of appropriate computational 
models and analyses.  
For the first part of this thesis, I applied to the infant gut microbiome an approach 
previously used to understand the order of colonization of microbial biofilms. Available 
metagenomic sequencing data from infant fecal samples collected for 2.5 years was 
queried to test whether or not the gut colonization process is a multi-step process, in 
which the organisms that are prevalent at a given time are closely related, in their 
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metabolic capabilities, to the organisms present at the previous time step. I further used 
network expansion algorithms previously developed for the study of large-scale 
biogeochemical evolution, to explore the dynamics and diet-dependency of the gut 
microbiome. These analyses suggest that metabolic relatedness among organisms is an 
important factor in the colonization process.  
The second part of my thesis explores the role of H. pylori in gastric cancer. I 
analyzed public microarray data for gastric AGS cancer cell lines infected with different 
strains of H. pylori differing in pathogenicity. Relative to uninfected AGS cell lines, low-
pathogenic H. pylori strain displayed no major metabolic dysregulation, consistent with 
the fact that H. pylori does not cause inflammation/gastric cancer in a majority of the 
human population. However, gastric AGS cell lines infected with highly pathogenic 
strains showed more significant differences, including the upregulation of purine 
metabolism, possibly consistent with an inflammatory response.  
The results in this dissertation thus offer insights into how the interplay between 
metabolic activity of human-associated microbes and their surrounding environment 
plays an important role in the colonization process as well as in pathogenesis. 
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CHAPTER ONE 
Introduction 
 
 
1.1 The Human Microbiome History and Predictive Modeling 
 
 Several individual microbes, as well as the whole 
ecosystem known as the human microbiome, play a fundamental role in different aspects 
of human health. They influence the rise of major diseases, like obesity, metabolic 
conditions, inflammatory bowel diseases, diabetes and even cancer. When they do not 
switch to a “disease state”, however, human-associated microbial communities are not 
only harmless, but also symbiotically contributing important functions to the human host. 
For example, they are responsible for producing essential vitamins like B12 and are likely 
helpful in keeping pathogens away 1 2. The power of microbiome-based diagnostics and 
therapy has already inspired several researchers and commercial ventures, especially 
based on the established notion that microbiome transplants can cure certain disease 
conditions 3. As a result, microbiome research has grown leaps and bounds within the 
recent years. Interestingly, most biomedical research in this area is based on empirical 
attempts and experimental methods. In addition to detecting microbial compositions 
before and after treatment many researchers have focused their attention on trying to 
understand the basic nature of microbial community interactions and spatio-temporal 
organization, as well as the interactions of the microbes with the host. In parallel to large 
experimental data collection and statistical analyses, these types of questions are also 
amenable to computer simulations and mechanistic models. These types of analyses can 
provide better understanding of the function and dynamics of the microbial community 
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and could also spearhead personalized microbiome-based interventions which can either 
be used as probiotics or biomarkers of diseases 4.  
 Computational models and analyses constitute an essential 
component of microbiome research, and can range from sequencing and analysis 
pipelines to simulations and machine learning methods. Broadly speaking, computational 
approaches, in addition to helping process and organize raw sequencing data, aim at  
characterizing or predicting different states of the microbiome and understanding their 
health-related consequences. The most active research area in computational biology of 
microbiomes is probably the development of sequence-based methods to optimally 
process amplicon (typically 16S rRNA) sequence and whole metagenomic data, and to 
use these data for functional and pathway mapping 5. Such functional analyses of 
microbiome data typically involve mapping the sequences onto databeses containing 
detailed annotations on specific processes. Databases commonly used include KEGG, 
Metacyc, Pfam, Uniprot of COG database 6 7 8 9. Not less important are tools for data 
visualization, such as Cytoscape and VisANT, which can be used to analyze individual 
pathways, or more complex networks 10 11. Additional recent approaches to microbiome 
research involve Machine Learning algorithms, such as Supporting Vector Machines 
(SVMs) and neural networks. Training SVMs with algorithms can categorize the 
microbiome and help predict dysbiotic (imbalance of organisms in the gut) or non- 
dysbiotic stages 12. In neural networks approaches, the microbial community structure 
and species abundances can be represented in matrix format, and used to predict the 
community behavior 13. In other types of computational methods that can be thought of as 
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“reverse ecology” approaches network analyses have been used to identify sets of 
compounds that would be necessary for the growth of certain organisms 14.  Finally, as 
explored in this dissertation, it is possible to use “network expansion” algorithms to try 
and infer, from an initial set of metabolites (known as seed set, and potentially mimicking 
the diet) what other metabolites/reactions would likely appear in a given community  15.  
 
1.2 The Human Microbiome Colonization 
 
 Understanding the dynamics and interactions of different microbial species is one 
of the most important challenges of human microbiome research, as this would pave the 
way to rational design of therapies. A specific aspect of the dynamics and interactions of 
human-associated microbial communities I will focus on is process of colonization. The 
order of colonization can be viewed as a temporally ordered sequence of taxa whose 
progression can be affected by several factors like the type of birth, diet, environment, 
age, stress, antibiotics and inflammation. The colonization of a new niche in the human 
host is an extremely complex process. In some cases, it is possible to identify in the 
colonization process (e.g. in the gut) two distinct steps. In the first step, ‘early colonizers’ 
first bind to the mucus membrane of the host, and prime the environment for ‘late 
colonizers’ 16. The colonization process can depend strongly on the early colonizers, and 
give rise to a diverse set of possible healthy and stable communities.  If the colonization 
process is disrupted at the initial phases, it can lead to serious repercussions for the set of 
organisms that would be dependent on the first set of microbes. For example, these 
secondary microbes could be commensal and beneficial organisms, whose absence could 
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cause the invasion of pathogens or disease 17. The colonization process is also known to 
impact significantly the health state of the host’s immune system 18.  In building 
computer models for the order of colonization of a microbial community, it is important 
to incorporate functional (metabolic) information about microbes as well as known 
details about interactions with the environment. Some of this complexity is captured 
efficiently by genome scale flux balance models of microbial metabolism. These 
approaches, initially developed to understand the physiology of individual organism, are 
now routinely applied to study complex communities19. Ultimately, the hope is that such 
mechanistic understanding of human-associated microbial communities will help us 
identify probiotics that can stir the microbiome towards desired states 20 and explore new 
avenues for the generation of new natural products, such as antimicrobials 21.  
  
In addition to studying computationally the general properties of 
the colonization process of a microbiome, my dissertation work focuses on the possible 
health effects of the interactions between a specific bacterium (H. pylori) and the human 
host, especially in connection to its possible implication in gastric cancer.  
 
1.3 H. pylori and its interaction with the environment  
  
 Helicobacter pylori is a unique organism that can thrive in 
the acidic human stomach lining. To survive in such a harsh environment, the bacterium  
converts urease in the cytoplasm into carbon dioxide and ammonia. This lowers the pH in 
the stomach and allows the bacteria to thrive. It survives best within pH of 4.0 – 8.0 22. H. 
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pylori is known to play an important part in gastric tumorogenisis by causing 
inflammation. This is believed to be mediated by the urease enzyme. The production of 
ammonia not only damages the stomach lining but causes dysregulations in several 
metabolic and signaling pathways (Helicobacter pylori infection, oncogenic pathways 
and epigenetic mechanisms in gastric carcinogenesis – Ding et al Future Oncol 2011). 
This microbe can be present in most people and cause no harm. It is becoming 
increasingly clear that only specific strains of this bacteria are associated with higher 
virulence to gastric cancer 23. 
 
1.4 Dissertation Aims  
  
My dissertation work has been centered around the following 
questions:  
1. Is the colonization process of a human-associated 
microbiome a multi-step process dominated by metabolic relatedness of organisms? 
2. Can one use diet information, and a network expansion 
algorithm REF  to infer properties of a community and the dependence of its organisms 
on the specific molecular component of the diet? 
3. Is mRNA dysregulation involved in H. pylori 
pathogenicity? In particular, do we observe dysregulation of pathways that can mediate 
interactions with the microbe? How do different strains exacerbate to different extents 
gastric cancer? 
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CHAPTER TWO 
Exploring the role of inter-species metabolic distance and diet on the order of 
colonization in human gut microbiome 
 
2.1 Background 
 
The genetic information present in the human body can be viewed as the set of the 
genomes of several different microbial species in addition to the human genome itself. 
The large number of prokaryotic, viral, and fungal genomes present in the human host, 
known collectively as the human microbiome, constitutes an integral of the human host 
and contributes significantly to its health, through functions that are still poorly 
understood24. One of the many ways in which the human microbiome affects us is the 
complex set of interactions between microbes and the immune system 25. Furthermore, 
the microbiome is known to provide enzymatic capabilities responsible for the 
biosynthesis of specific molecules that are necessary for our health, but that ore otherwise 
non-producible by our body. These metabolic functions include the production of 
vitamins (B12) as well as important enzymes that can degrade complex carbohydrates, 
such as CAZymes (carbohydrate active enzymes) 26 27. In addition to interacting with the 
human host, microbes are thought to interact heavily with each other, forming ecological 
networks that may significantly affect the microbiome composition and dynamics, as well 
its influence on our body. One of the ways in which the human environment and 
interspecies interactions can dramatically affect the whole microbiome dynamics is 
through the specific order of colonization, and associated structure of multi-species 
communities.  
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The colonization process of a microbial community, and its temporal and spatial 
aspects, have been studied extensively 28 29. In environmental research, microbial 
successions are known to consistently involve specific taxa with cyclical recurrence that 
may reflect seasons, or with specific orders of appearance after disturbances 30. Microbial 
successions are also very important in the human microbiome. The idea of using 
sequencing to map the order of colonization of the infant gut had been used already in 
2002 31. For the study of more directly accessible microbial colonies, such as in the case 
of the human oral microbiome, detailed scenarios of the order of colonization had been 
mapped through direct observations of the biofilm, or in vitro experiments of pairwise 
interactions, summarized in the literature as global putative networks 32 16.  
While in its simplest form, the order of colonization of a community can be 
viewed as a temporally ordered sequence of taxa, the seeding and progression of a 
microbial ecosystem can depend on multiple factors, and the existence of a clearly 
defined and deterministic succession is still debatable. One hypothesis about microbiome 
colonization in the human gut posits that it constitutes a complex process comprising of 
two major steps. In the first step, ‘early colonizers’ first bind to the host, and prime the 
mucus lining, preparing the ground for ‘late colonizers’ 16. This process can create a 
diverse community, as suggested by the ‘saturable niche hypothesis’ 33. According to this 
theory if a particular species has saturated or occupied a particular niche of the human 
intestine lining, it will prevent other strains of the same species to occupy the same area. 
It will however help related species to grow around it, reducing competition and 
promoting cooperation. This is because if there are too many similar species they would 
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be competing for the same food source. Conversely if they were functionally dependent   
they would facilitate each other. For example, Bacteroides thetaiotaomicron utilizes 
glycans from the host and the host diet to grow. Knocking out genes or transcription 
factors that target the glycan utilization pathway thus affects the glycan catabolism and 
colonization of other microbes 34. This is because these specific glycans that are secreted 
into the extracellular space by this bacterium can be a food or energy source for many 
bacteria and thus promotes diversity and stability in a community 35. 
This initial organization of the microbiome plays an important part in defense 
against pathogens and also prevention of colonic tumorogenesis 36.  Extensive research 
has been done to show how early colonizers interact with each other and with the late 
colonizers. For example, on the tooth surface the early colonizer Streptococcus has 
special enzymes that bind to the salivary receptors on the tooth surface and prime the 
environment for later colonizers like Actinomyces and Fusobacterium. This creates a 
dynamic community in the oral cavity and is important in avoiding periodontal diseases 
37.  The process of early colonizers priming the niche for late colonizers is also seen in 
other microbial niches in the human host.  
In humans, microbiome colonization can be affected by several non-pathologic 
factors like the type of birth – vaginal or caesarean, feeding patterns – breast fed or 
formula fed, diet at adult age and also the environment 38 39. However, disease and/or 
antibiotics can cause significant imbalance in the taxonomic abundance and functions of 
human-associated microbes, disrupting the ecosystem structure, and affecting the 
succession upon colonization or re-colonization. This disruption in microbiome structure 
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can in itself have further consequences, i.e. cause severe diseases due to abnormal 
immune response, lack of vitamins and disrupt metabolic pathways, e.g. those involving 
carbohydrate degradation 2 26 40. Therefore, it is important to try and better understand the 
colonization process, its predictability, and its dependence on mechanisms whose 
manipulation may help control the microbiome for therapeutic purposes. 
The microbial colonization process is often perceived as being strongly dependent 
on ecological interactions and host diet, such that organisms close to each other in the 
succession tend to be dependent on each other, or to have related metabolic functions 41. 
In this chapter I will use computational analyses to ask whether and to what extent the 
colonization process in the human gut is recapitulated and explainable in terms of the 
metabolic enzymes and functions associated with the organisms that form the succession. 
In other words, will a random colonization be more robust than the actual colonization 
structure. A similar idea had been previously explored in the oral microbiome 42 taking 
advantage of the known structure of the dental plaque biofilm. In the oral microbiome 
case, it was found that the layers of microbial species could be translated into layers of 
enzymatic functions, which could be viewed as building gradually upon each other in a 
way that was consistent with the known order of colonization. For the human gut 
microbiome, the problem is somehow different, as the actual network of bacteria and 
their interactions is not known, and the information available is typically just the 
composition of the microbiome at different time points. Analyzing this information in 
search for signals of a metabolic basis for the order of colonization poses certain 
challenges, which will be described later in the chapter.  
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The dataset that I will be using is a time series 16S rRNA data that divides the 
samples into different diets 43 (See Section 2.2.1 for addtional  details). To explore the 
order of colonization I will mainly be focusing on comparing the microbial composition 
between different time points within a given diet regime (“intra-diet”). This is because 
the hypothesis of the order of colonization algorithm we will apply is that organisms 
build on each other’s capabilities, based on an otherwise steady environment. Thus, for 
each diet, we will explore a different colonization process.  
The effect of diet on the microbiome, and on the colonization process has been 
studied abundantly. For example, prior work showed that shifting mice from a low fat, 
plant polysaccharide rich diet to a high fat, high sugar diet caused a shift in the microbial 
diversity 44. Mice fed on complex microbiota-accessible carbohydrates (MACs) found in 
dietary fiber have a higher microbial diversity than those fed on simple carbohydrates. 
This diversity even decreases across generations and is irreversible unless missing genera 
over the generations are manually re-introduced 45.   
Given the dependence of the microbiome on diet, it has been hypothesized that 
knowledge of the microbial community composition can provide direct information about 
diet. Eating a plant based diet causes increase in organisms like Roseburia, Eubacterium 
rectale, and Ruminococcus bromii that are robust in complex polysaccharide digestion 
whereas an animal based diet causes an increase in bile tolerant organisms like Alistipes, 
Bilophila, and Bacteroides that metabolize proteins 46.  
Diet can affect host energetics thereby affecting various aspects of health and increasing 
the risk of obesity 47 48. Another crucial aspect of host-microbiome interaction is the 
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effect that diet can have on different microbial taxa, which in turn can modulate the 
immune system. For example, human breast milk contains many oligosaccharides 
(HMOs). Its microbiome is dominated by Bifidobacterium infantis. HMOs are one of the 
most abundant compounds found in breast milk and they are a major food source for B. 
infantis. This bacterium, in turn, modulates in an important way the baby’s immune 
response 49.   
In order to understand the shift in microbial community as a function of diet, 
several studies have performed community analyses based on sequencing data. However, 
very few attempts have been made towards understanding this connection from the 
perspective of microbial ecology and network-based approaches 50. The working 
hypothesis of my project is that a network based approach can be valuable to relate diet 
and microbiome. Thus, in this chapter I will be discussing a mechanistic approach to look 
at dynamically changing communities in the infant gut as a function of diet. My analysis 
will be based on molecular data about the diet, network algorithms using KEGG pathway 
information, and 16S rRNA sequencing data. The diet information is represented in the 
form of an array of molecules or constituents that make up the food, with corresponding 
estimated abundance. This was carefully done utilizing the metadata collected for the 
subject and manually curated with the help of a Bioinformatics graduate students, Lili Ge 
and is discussed in details below. 
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2.2 Methods 
2.2.1 Data 
 
 The data I used for the project was obtained from previously published work. I 
will summarize here briefly some key information about the dataset. Infant gut 16S rRNA 
sequencing data that was collected from fecal samples of a healthy infant from the time 
of birth to an age of 2.5 years during diaper changes 43. As described in the original 
paper, around 60 fecal samples were collected including one from the mother at the time 
of birth. The average read length in the data per sample is about 250. Following sample 
collection, the microbial cells were lysed and purified the V2 region of the 16S rRNA 
genes was subjected to amplification using forward and reverse primers which were 
represented as the following 5′-
GCCTTGCCAGCCCGCTCAGTCAGAGTTTGATCCTGGCTCAG-3 and 5′-
GCCTCCCTCGCGCCATCAGNNNNNNNNNNNNCA-
TGCTGCCTCCCGTAGGAGT-3′ respectively. The italicized tag is 454 Life 
Sciences’ primer and the bold tag is the bacterial primer. Following these steps, and 
appropriate barcoding, the samples underwent a 454 Pyrosequencing using a Roche 454 
FLX pyrosequencer. The 16S sequencing reads were then submitted to the SRA 
(Sequence Read Archive) database from where I downloaded the fastq files for analysis 
51. There was also additional information collected in terms of the different diets and 
antibiotics administered to the infant. Based on this the time series data was divided into 
4 steps. Table 1 shows the break up for the diets. 
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2.2.2 Pre-processing 
 
I analyzed the 16S data using the QIIME (Quantitative Insights Into Microbial 
Ecology; qiime.org; version 1.9.0) software to gather information regarding what genera 
were present in the time course samples 52.  The QIIME pipeline was constructed in the 
following steps. First a mapping file was created that mapped the samples to their 
barcode (a DNA sequence assigned to the samples that allows them to be multiplexed and 
read), linkerprimer sequence (a sequence that helps to amplify the 16s rRNA in the 
sample) and also contains metadata like infant age and diets. Next, the BLAST program 
was used to analyze the results and align it to a reference database 53. Following prior 
work with 16S rRNA, I used the Greengenes database to attribute samples to organisms.  
Using this database I could match the data samplings to 97% of the genome and find 
representative OTUs (operational taxonomic unit) 54. Moreover, to avoid including 
spurious matches, I used a fairly stringent cutoff for the e-value in QIIME. In particular, 
Step Sample/Days Number of 
Time-points 
Diet 
1 Meconium,4,5,6,10,14,16,1
9,23,27,31,33,48,55,57,63,
64,70,77,84 
20 Breast Milk 
2 118,128,133,134,139,141,1
46,161 
8 Breast Milk + Rice Cereal 
3 172,173,195,202,206,240,2
44,252,265,273,280,294,29
7 
13 Breast Milk + Rice Cereal + 
Formula 
4 454,468,469,539,568,623,7
45,831,835,838 
10 Cow’s Milk + Adult Diet 
Table 1: Description of the time series data and the diets administered  
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this was set to a high significance level (less than or equal to 0.001). Following these 
steps, taxonomy was assigned to the samples using a cut-off of 90% similarity to 
Greengenes using BLAST 53. Phylogenetic tress were then created in QIIME using their 
default FastTree algorithm 55. This led to the generation of a final OTU (operational 
taxonomic unit) table that contains the representative organisms is a particular time-point 
and their abundances.  
 
2.2.3 Constructing a network of interconnected and random organisms for the infant gut 
 
 This OTU table with assigned taxonomy was then used to calculate if metabolism 
plays a key role in determining the order of colonization among the diets.  To do so, I 
compared organisms appearing in an ordered progression to a random sampling of the 
data. The algorithm is best described through the following toy model example. Let there 
be 3 lists of organisms for 3 time points 1, 2 and 3 respectively. Assume that at each time 
point three different taxa are present, e.g. {A, B, C}, {A, D, E} and {E, F, G} 
respectively. For the order-preserving path I tried many strategies.  
Strategy 1 
I randomized the organism order appearing within a day and then found pairwise 
distances of all pairs. This meant my list of organisms for time point 1, 2 and 3 are now 
{B, A, C}, {D, E, A} and {G, F, E}. I then calculated the pairwise distance for {B-A, A-
C, C-D, D-E, E-A, A-G, G-F, F-E} which represented my ordered path.  
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Strategy 2 
I randomly chose a genus from one of the time points without allowing repeats and 
construct a network. This means that my new network is choosing one from each time 
point {A, D, F} and the pairwise distance of the path would be {A-D, D-F}. 
Strategy 3: I randomly chose a genus from one of the time points allowing overlapping 
organisms in the time point if it happened to show up. The path created in the method 
could be {A, A, E} and the distances would be {A-A, A-E}. 
Strategy 4 
I also removed the low occurring genera and followed strategy 2 and 3 i.e. if genus A was 
less abundant it was removed before sampling. 
Strategy 5 
The last strategy that we chose was to a modification of Strategy 3 in which we look 
between diets. This is because sample collection had higher frequency between diets 
compared to across all time-points. Also, the organisms between diets might be not 
related closely with respect to their biochemical function and enzyme content.  
For the random path let there be 3 lists for time point 1, 2 and 3 respectively given 
as {A, B, C}, {A, D, E} and {E, F, G}. Once again I experimented with various 
strategies.  
Strategy 1 
I shuffled all the days and organisms found within the infant. So, the list would now look 
like time 2 - {D, A, F}, time 3 – {A, G, E} and time 1 – {E, B, C}. The path would then 
be {D-A, A-F, F-A, A-G, G-E, E-E, E-B, B-C}. 
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Strategy 2 
I shuffled only all the organisms without changing the order of days within it. So, the list 
would now look like time 1 - {D, A, E}, time 2 – {A, G, E} and time 3 – {F, B, C}. The 
path would then be {D-A, A-E, E-A, A-G, G-E, E-F, F-B, B -C}.  
Strategy 3 
Next I only randomized the days. So now the path would be time point 2 – {A, D, E}, 
time point 1 – {A, B, C} and time point 3 – {E, F, G}. The distance would be calculated 
between {A-D, D-E, E-A, A-B, B-C, C-E, E-F, F-G}. 
Strategy 4 
(A) For this the days and organisms were shuffled like Strategy 1 but I only chose 1 
organism from every time point without repeat. Using the example from Strategy 1 the 
path would now be {D, G, B} and the distances would be {D-G, G-B}.  
(B) I also tried this same strategy removing the less abundant organisms. So, if A is less 
abundant it was removed from the analysis before using Strategy 4A. 
Strategy 5 
The last strategy was the same as Strategy 4A except we only looked at organisms in the 
same diet. Repeats were allowed. The reason is the same as highlighted in Strategy 5 for 
ordered path selection.  
Finally, I also wanted to compare the random path in a diet to a completely 
random set of organisms. For this I queried KEGG for a list of all genera and created an 
arbitrary list of those to compare them to the ordered and random diet 6.  
 
 17 
2.2.4 Curating genus level enzyme information and Calculating enzyme distances for 
consecutive genera in a network 
 
 Each organism is associated with certain biochemical functions, which are 
encoded by enzymes. The KEGG database contains information for these enzymes in the 
form of Enzyme Commission (EC) number that are ascribed to an organism’s genome 6. 
Querying KEGG rest style API I can create a binary matrix by estimating the presence or 
absence of a particular enzyme in a species. This was done on July 22, 2016. I queried 
around 4300 organisms out of which 3815 belonged to bacteria, with a total of 5518 
enzymes. Since I wanted to perform a genus-level analysis, but KEGG returned matching 
to species (with several species belonging to a given genus), I created a mapping file that 
mapped each species to its genus. This gave me 961 bacterial genera.  
To create a binary genus to enzyme matrix the following strategy was adopted. If 
the enzyme was present in 50 percent of the species in the genera it is denoted as 1 
(present) else, it’s 0 (absent).  Given this binary profile for each genus we can now 
calculate the jaccard’s distance between the pairs of genera. 
 For example, consider two genera A and B with binary EC vectors 𝑉𝐴 and 𝑉𝐵. If 
enzyme x is present in genus A , 𝑉𝐴 = 1 and if it’s absent, 𝑉𝐴 = 0. Using this, Jaccard’s 
Distance is calculated as follows: 
J(A, B) =  1 −  
VA ∩  VB
VA  ∪  VB
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It is the difference of the ratio of enzymes that are present in both A and B versus the 
total enzymes that are present in A and B. If J(A,B) = 1 then the genera are highly diverse 
and when J(A,B) = 0 that means that genus A and B are metabolically alike. 
 The jaccard’s distance metric was used between pairs of genera in 3 pathways – 
the order preserving, the random path in a diet and the random path in KEGG to calculate 
the metabolic proximity of organisms. This process was repeated 1000 times for each of 
the 3 networks to increase the sampling space and calculate the efficiency in the order of 
colonization using enzyme data. 
 
2.2.5 Curation of Diet for Network Expansion 
 
The next part of the chapter deals with using network based approaches to 
understand the association of diet with the microbiome. For this information about the 
infant diet was duly noted in the Koenig et al paper. They classified the time series data 
into 4 steps based on the diet. Using this information, I and another graduate student Lili 
Ge were able to look at the metabolites that constituted the diet. Literature reviews were 
done for a detailed curation of the diet 56 57 58 59 60 61. This was then analyzed with the 
help of the USDA website Release 28, version September 2015 62. Since the food intake 
changes with age, we even went a bit further and calculated the consumption of that 
nutrient per day based on the infant’s intake of a food source during a certain age. The 
ages chosen and their diets are highlighted in Table 2. Also, highlighted in 
Supplementary Table 1, 2, 3 and 4 are the complete metabolite set of diets.  
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There were several challenges that we had to address while curating this dataset. 
One of them was dealing with complex macromolecules. Some examples of these were 
casein found in dairy products and lutein a carotenoid found in green leafy vegetables and 
starch 63 64 65. The challenge with them was that giant molecules could not take part in 
simple reactions even if they were important. To overcome this these complex macro-
molecules were broken down into simpler amino acids using literature references that are 
utilized by the body 66 67 68. One such example of this is casein, which is mentioned in 
Supplementary Table 5. Finally, not all the compounds in the diet was used for network 
expansion. This was because when most of the compounds were present in the diets the 
difference between the diets became minimal. As a result, several approaches were used. 
Approach 1 
This involved only keeping the abundant seed compounds. Different thresholds for the 
compounds were tried which were – 5%, 10%, 25%, 30%, 40%, 50%, 60%, 75% and 
100% (all the compounds). However, since we were only taking the top compounds the 
Diet Age 
Mother’s Milk 2 months 
Mother’s Milk + Rice Cereal 4 months 
Mother’s Milk + Rice Cereal + Formula + Peas 6 months 
Cow’s Milk + Adult Diet (Fruits – Apples, Banana, 
Proteins – Boiled Egg, Chicken Nuggets, Fish Sticks, Lentils, 
Diary – Yogurt, Cheddar Cheese, Butter,  
Starch – Rice, Cereal, Pasta, Bread, Potatoes) 
1.5 years 
Table 2: Representative ages on the infant with the diet that was curated  
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difference could not be noted as the top compounds did not change sufficiently over 
diets. Also, if I used all the seed set metabolites the network expansion of all the diets 
converged to the same unless the goal was looking at pre-adult diet vs adult diet. 
Approach 2 
The strategy that I used thus involved looking at log abundance. This is because the 
abundance of the compounds was measured over number of orders of magnitude. I used 
many cut-offs to see the network size and then decided to do a case study of all the 
metabolites (as used in Supplementary Table 1-4), median abundance of -5 and a strict 
cut off of 0. This metabolite set is highlighted Supplementary Table 6 and 7 and 
Supplementary Figure 1. Table 3 also shows the number of metabolites included for the 
seed set threshold.  
 
 
2.2.6 Network Expansion and calculating enzyme profile for a diet 
 
 Network expansion is an iterative algorithm that can predict the state final state of 
system given a set of initial inputs (generally 2) known as the “seed set”. This algorithm 
has been extensively used in in many evolutionary studies and also analyzing the input to 
Cut-off Diet 1  Diet 2 Diet 3 Diet 4 
All 59 65 74 129 
-5 54 60 71 124 
0 11 12 12 26 
Table 3: Number of metabolites corresponding to the log abundance thresholds 
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output relationship of a metabolic system over time 69 70. If we look at the diet aspect it 
does supply important molecules and affects the metabolic system and also if we look at 
the microbiome it does function as a list of organisms with enzymes. As a result, this 
approach can be used as a novel method to find the effect of diet on the microbiome and 
the 16S data can be used as a tool to verify this network approach. The seed set in this 
case would involve two things, firstly a set of all the reactions available from KEGG and 
secondly the list of metabolites curated from the diet above. 
 Reactions from KEGG were filtered based on several criteria for the input 
reaction list. Firstly, the reactions from KEGG involve several co-factors that might be 
important for the sustenance of a reaction. The assumption during this process was that 
the co-factors were presumed to be present and as a result their dependence on a reaction 
was eliminated from the enzyme stoichiometric matrix. These co-factors were ATP, 
ADP, AMP, NAD, NADH, NADP, NADPH, FAD, FADH, COA and ACOA. Secondly, 
a list of spontaneous reactions was added to the KEGG reactions that occur without any 
enzyme. Thirdly, unbalanced chemical reactions were removed from the list as they don’t 
adhere to the law of conservation of mass. Apart from that I also obtained a list of 
compounds that correspond to reactions from KEGG. Thus, if we summarize the inputs 
from KEGG and the diet as the following matrix: 
 
K = {compounds=1…5944 , rj=1…6880 }  
where rj is the set of reactions  
Di=1…4 = compounds present in each diet i     
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In the final step, network expansion acts as an operator between the information 
from KEGG and the curated diet. As mentioned above, when I put in the initial seed set I 
get a subsequent list of compounds and reactions that can be generated from the iterative 
step and so on and so forth. Finally, after the network has reached saturation I stop the 
algorithm and it gives me a final list of compounds and reactions. The reactions were 
then mapped to their consequent enzymes and finally a binary matrix or binary profile α 
for each diet was created as: 
 
Network Expansion →  NE 
NE(Di , K) →  𝛂𝐢 = [𝟎, 𝟏, … , 𝟎, 𝟏]  
where  αi ,j = 1 if reaction rj is present in in diet i for NE(Di , K)   
 
2.2.7 Calculating the Euclidean distance between diet profiles and the 16S data 
 
 The first step in this method was that I calculated the probability of a genus 
present in the infant microbiome data to have a particular enzyme. The genera that are 
found in the data was isolated and then multiplied with the abundance of those organisms 
that was calculated by QIIME and their enzyme content from KEGG. This gave me the 
enzyme abundance matrix.  
The second step involved calculating the frequency of species that were found in 
a particular genus. The enzyme abundance matrix in the first step was then divided by the 
number of species found in a genus in the second step to get the enzyme probability of 
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the genera found in the data. Let us call this final matrix 𝛿𝑔 where g represents the 
genus. 
 
2.2.8 Finding the top 20 organisms in the infant microbiome that can differentiate 
between diets 1, 2, 3 and 4 
The network expansion profile for each diet is 𝛼𝑖 and the enzyme profile each 
genus in the data is 𝛿𝑔. The Euclidean distance between them is denoted as: 
E(αi, δg) = di ,j  
where d is the distance of genus g with the NE in diet i 
  
The distances for each diet are then ranked with the lowest distance values. This 
would mean that those genera have the closest resemblance to the network expansion 
have smallest distance. The thing to note is that all the genera are present in the infant 
data but they might be ranked differently in the diets due to their enzymatic similarity 
with the expanded network. I chose to look at the top 20 organisms that resemble an 
expanded network expansion profile.  
 
2.3 Results 
2.3.1 Validating Results with Source Data 
 
Since QIIME was also used in the source paper for the data with some minute 
changes in the method of assigning taxonomy to the infant specimens I wanted to see if 
our method could recapitulate similar results 43. For this, I compared the phyla 
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abundances that were obtained in the in the published paper alongside abundances that 
we calculated with QIIME as seen in Table 4. 
From Figure 1 we can see that there are 2 types of colonizers as mentioned before 
in the chapter.  The ‘early’ colonizers are colored in purple. They are the Firmicutes. 
They are then followed by the ‘late’ colonizers Bacteroidetes in blue. The Bacteroidetes 
flourishing in the later half makes sense as they are mainly dependent on carbohydrates in 
the host diet 71. Further validation can be seen in Table 4. Thus, my analysis is in 
agreement with the published analysis results. Apart from that, looking at Figure 1, the 
blast analysis integrated with QIIME yields more phyla compared to the analysis 
performed. This was because the source data used cd-hit which uses a short word filtering 
72. For a sample to be similar to a reference genome with a particular threshold they have 
to have a certain number of base pairs overlapping. This way cd-hit can skip many 
pairwise alignments which a typical blast search would not. 
 
 
 
Organisms 
(Koenig) 
Diet 1  Diet 2 Diet 3 Diet 4 
Actinobacteria 1.5 % 2 % - - 
Bacteroidetes 0.5 % - 50 % 50 % 
Proteobacteria 10 % 20 % 19 % 8.6 % 
Firmicutes 88 % 78 % 31 % 41.4 % 
A 
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2.3.2 Order of Colonization is strongly correlated to metabolic distances for Diet 1, 3 
and Diet 4 
 
 The distributions of the order of colonization are then plotted for the ordered and 
random paths as seen in Figure 2 A, B, C, D. We see a good separation between the 
above networks for Diet 1, 3 and 4. This can be noticed as the distributions for the 
ordered network has lower jaccard’s distance and is aligned more to the left when 
compared to the random network that has a greater jaccard’s distance and is shifted more 
towards the right. An explanation to this can be that for Diet 1 (mother’s milk) I see 
emergence of genera that are inter-related to each other in function based on the food 
source. However, if I shuffle the ordering of the organisms they might not be able to 
digest the byproducts of the food source in the order that they appear in the diet. 
Similarly, for Diet 3 and 4 that comprises of pre-adult and adult nutrition the organisms 
have to work in tandem to utilize the complex molecules generated in the intermittent 
steps of metabolic assimilation. On randomizing the genera and hence enzymes we tend 
Organisms 
(QIIME) 
Diet 1  Diet 2 Diet 3 Diet 4 
Actinobacteria 0.4 % 2 % 0.5 % 0.2 % 
Bacteroidetes 0.1 % 0.1 % 48 % 60 % 
Proteobacteria 15 % 15.9 % 14 % 11 % 
Firmicutes 80 % 82 % 35 % 28.7 % 
Others - - 2.5 % 0.1 % 
B 
Table 4: (A) Percent of organisms from Koenig paper, (B) Percent of organisms from the QIIME pipeline 
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to break this co-operation pattern thereby increasing the metabolic distance between the 
organisms.  
 The fact to note is, that before Diet 2 (mother’s milk and rice cereal) antibiotics 
was administered to the infant as the child had a bout of fever. This could hamper the 
abundance of certain organisms present in the baby and thus their enzymatic function. As 
a result, I see that the ordered path and the random path within the diet overlap. However, 
on calculating the Wilcoxon Rank test to determine whether the distributions are different 
I do see a significant P- value which states that the ordered path is indeed smaller in 
distance than the random path in the diet. This is demonstrated in Table  
5. 
 
 
 
 
 
 
 
 
 
 
 
2.3.3 Organisms can differentiate between diets 
 
 Abundance of organisms was normalized across each time point by QIIME. This 
means that their total abundance adds up to 1 in a particular time step. Using this data and 
also overlapping the information of the days and diet I plotted a PCA plot. The aim was 
to see if the samples could be sorted out based on their diet labels Figure 3. From the 
Diet Diet v/s Random Diet v/s KEGG 
Diet 1   1 × 10−101  8 × 10−321 
Diet 2 1 × 10−14 6 × 10−176 
Diet 3 8 × 10−93 2 × 10−299 
Diet 4 1 × 10−94 4 × 10−309 
Table 5: Calculated Wilcoxon P-Value between the ordered path v/s random path in a diet and 
ordered path and random path in KEGG 
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figure, it is evident that the organism content in each day can cluster well with time series 
data. Diet 1 and Diet 2 tend to cluster together and samples in Diet 3 and Diet 4 cluster 
near each other. There are some samples in Diet 3 that tend to group near Diet 1 and Diet 
2. The anomaly could be explained by the fact that antibiotics was administered to the 
infant before collecting the samples. This could have upset the diversity of organisms in 
the beginning of that set of data. 
 On analyzing the alpha diversity of the samples, which measures the diversity of 
the organisms in a community/time step I also noticed that with a more complex diet the 
organism complexity and number of microbes increased Figure 4.  
 
2.3.4 Enzymes can differentiate between diets 
 
 In order to show that network expansion approach using diet and KEGG enzyme 
information could produce any signal among different diets I also plotted the enzyme 
content in each time point labeled with the diet information. The enzyme information for 
the time points was obtained by looking at what organisms were present in a particular 
day and querying KEGG to see what they contributed enzymatically. This also showed 
the enzymes could indeed distinguish between diets Figure 5. This was not surprising as 
the organisms and the diets are closely related as shown in the section 2.3.3. This meant 
that network expansion approaches could be exploited to find differences between the 
diets. 
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2.3.5 Network Expansion results 
 
Firstly, network expansion with different seed set cut-offs produced different sets 
of reactions to be turned on and off between diets shown in Supplementary Table 8 to 10. 
As seen in Supplementary Table 9 the log abundance of metabolites over 0 does not 
produce many reactions between diets. This proves that taking only abundant metabolites 
is not essential for a good network expansion. We need low abundant vitamins, 
molecules and co-factors like biotin for certain reactions to turn on 73. Since the threshold 
of seed compounds over 0 produced few changes in the reaction among diets as shown in 
Supplementary table 9, I only concentrated in the network expansion results of the other 
2 thresholds.  
 To demonstrate the success of the network expansion method with literature, I 
grouped the top 20 organisms that are closest to the network expansion profile given in 
Table 6.  
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Diet 1 organisms Diet 2 organisms Diet 3 organisms Diet 4 organisms 
Clostridium Veillonella Lactobacillus Bacteroides 
Streptococcus Clostridium Veillonella Prevotella 
Veillonella Lactobacillus Ruminococcus Ruminococcus 
Staphylococcus Bifidobacterium Clostridium Faecalibacterium 
Hafnia Eubacterium Enterococcus Blautia 
Enterococcus Enterococcus Prevotella Coprococcus 
Prevotella Streptococcus Streptococcus Streptococcus 
Corynebacterium Blautia Akkermansia Clostridium 
Gluconacetobacter Enterobacter Eubacterium Roseburia 
Bacteroides Actinomyces Faecalibacterium Enterococcus 
Bifidobacterium Staphylococcus Blautia Veillonella 
Enterobacter Klebsiella Bacteroides Akkermansia 
Klebsiella Ruminococcus Bifidobacterium Eubacterium 
Actinomyces Rothia Coprococcus Parabacteroides 
Rothia Corynebacterium Roseburia Haemophilus 
Finegoldia Atopobium Klebsiella Pseudomonas 
Campylobacter Prevotella Enterobacter Megasphaera 
Haemophilus Coprococcus Actinomyces Alistipes 
Anaerococcus Citrobacter Haemophilus Hafnia 
Roseburia Eggerthella Atopobium Anaerostipes 
 
 
 
 
Table 6: Top 20 organisms with threshold of -5 and no threshold 
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The thing to note is that these organisms are present in most samples of the 
dataset but they might necessarily not be the top candidates to resemble the expanded 
network. After I obtained a list of the top 20 organisms in each diet I looked at which 
organisms appeared to be unique to a diet based on the list. Those are marked in red in 
the table labelled as specialists in the diet. The ones in green were those organisms 
found across all the diets and was labelled as generalists. These were – Streptococcus, 
Clostridium, Ruminococcus (found in Diet 2 – 4), Bifidobacterium (found in Diet 1 – 3), 
Veilonella, Prevotella and Enterococcus. Literature suggests that the first 4 out of these 
are indeed found in most human gut microbiome 74.  
 I was more interested in the specialists in the diet and upon closer inspection of 
some organisms I found out that some genera in Diet 1 and Diet 4 were well correlated 
with certain foods. For Diet 1 among the 4 specialists found in the top 20, one of them 
was Gluconacetobacter that is a distinctly associated to the breast microbiome 75. This 
means that this genus was transferred from the mother to the infant sample via the diet 
(milk) during breast-feeding. This also means that the algorithm can also tell us 
something about the environment of origin of the bacteria. Also found in the same diet 
was Finegoldia where studies have shown that this is mostly present in the infant during 
days 4-6 of the milk diet 76. As a result, this one is not a top-ranking organism to the 
network expansion in Diet 1. Upon inspecting the adult diet (Diet 4) there were 5 
specialists in the top 20 – Parabacteroides, Megasphaera, Alistipes, Pseudomonas and 
Anaerostipes. The first 3 out of those are strongly correlated to an animal diet with is 
why they show up in the adult diet and not in the pre-adult one 46 77. 
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 Apart from the literature lookup I also performed a statistical analysis between the 
top 20 organisms in each diet with the aim to predict if these could differentiate between 
the diets. Using a Kolmogorov-Smirnov (KS) test and Euclidean distance of the microbe 
to a particular network expansion profile I was able to deduce that the distributions of 
organisms in Diet 1 were indeed different when compared to Diet 2 (𝑝 𝑣𝑎𝑙𝑢𝑒 =
7.2 𝑥 10 −4), Diet 3(𝑝 𝑣𝑎𝑙𝑢𝑒 = 2.4 𝑥 10 −7) and Diet 4(𝑝 𝑣𝑎𝑙𝑢𝑒 = 5.5 𝑥 10 −10) 
respectively as seen is Figure 6 and 7. This also shows that not only can the algorithm 
can distinguish between organisms in a diet but also the signal is more pronounced in 
pre-adult diet vs adult diet. 
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Figure 1: Phyla organization in the infant gut from QIIME analysis with legend  
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A 
B 
Figure 2: (A) Order of Colonization in ordered Diet 1 vs Random paths in Diet 1  
(B) Order of Colonization in ordered Diet 2 vs Random paths in Diet 2  
(C) Order of Colonization in ordered Diet 3 vs Random paths in Diet 3  
(D) Order of Colonization in ordered Diet 4 vs Random paths in Diet 4 
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Figure 3: OTUs can distinguish between diets 
Figure 4: OTU diversity increases with the diet complexity  
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Figure 5: Enzymes can distinguish between diets 
Figure 6: KS Test to show top 20 organisms can differentiate between diets – threshold -5 
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Figure 7: KS Test to show top 20 organisms can differentiate between diets – no threshold 
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2.4 Discussion 
 
 
 From all the above analysis, I can conclude that metabolic proximity does play an 
important role in determining the order of colonization. Since the random path always 
performs slightly worse in the enzymatic distance than the sequential or ordered path. 
Biologically this also makes sense as in the complex gut ecosystem the organisms exist 
mostly in cooperation and the early organisms prime the environment for the latter ones.  
 However, this analysis does not take into account multiple hosts. Though it does 
corroborate the signal found in the oral microbiome 42, further studies need to ascertain 
the strength of enzymes in the colonization pattern. 
 I can also see a clear trend in the abundance patterns of the organisms increase 
and decrease with certain food molecules suggesting that there is a correlation to the 
organism OTUs and its biochemical function.  These OTUs and their enzymatic content 
can also distinguish between diets. This means that if diet curation is possible along with 
enzyme information of the organisms present, network expansion can be performed. This 
is a novel method to predict what microbes would resemble a diet closely. This is what I 
have done for the second part of this chapter and used literature to corroborate these 
findings.  
 Network expansion though partially successful has some issues that can be 
improved upon. The foremost thing is that literature reviews are only available for adult 
and neonatal diets. There isn’t enough literature for specialized infant diets like Diet 2 
and Diet 3. Also the curation of the diet was approximated to most infants specifically for 
Diets 2 – 4 including formula and amounts used.  It was not specific for this dataset. The 
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other concern is the input compound and reaction seed set. Starting off with the 
compound set I chose to include only the low abundant metabolites. On using all the 
metabolites, the network for all diets saturate to the same result making this algorithm not 
very sensitive to the changes. However, a better approach of figuring out the importance 
of each compound would be to look at the biomass reaction of a genome scale flux 
balance model 78. The biomass equation in such models provide information as to what 
molecules are important for the organism growth. This can be used to set the threshold 
for the compounds in the seed set. In general, there are 2 types of biomass reactions – 
gram positive and gram negative microbes which require different compounds to survive 
and different thresholds for these. Also, there are several assumptions made for the 
reaction set. The co-factors were removed from the stoichiometric matrix and there are 
many special organism reactions which were not considered. These modifications could 
increase the signal and sensitivity of this algorithm. 
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Supplementary 
 
Table 1: Complete metabolite set of Diet 1 (Mother’s Milk) 
Compounds Names Total 
C00001 Water 700.7 
C00023 Iron 0.00026 
C00034 Manganese 0.000208 
C00038 Zinc 0.0013 
C00070 Copper 0.000416 
C00072 Vitamin C 0.039 
C00076 Calcium 0.26 
C00114 Choline 0.1274 
C00120 Biotin 6.57E-06 
C00187 Cholesterol 0.104 
C00219 Arachidonic acid 0.208 
C00238 Potassium 0.416 
C00243 Lactose 55.12 
C00249 Palmitic acid 7.358 
C00253 Niacin 0.00143 
C00255 Riboflavin 0.000286 
C02679 Lauric acid 2.054 
C00305 Magnesium 0.026 
C00314 Pyridoxine 0.000078 
C00378 Thiamin(e) 0.000104 
C00473 Vitamin A 0.001001 
C00504 Folate 0.000052 
C00698 Chloride 1.001 
C00712 Oleic acid 11.804 
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C00719 Betaine 0.09204 
C00864 Pantothenic acid 0.001794 
C01330 Sodium 0.13 
C01382 Iodine 4.77E-05 
C01529 Selenium 1.82E-05 
C01530 Stearic acid 2.34 
C01571 Capric acid 0.494 
C01595  Linoleic acid 2.99 
C01628 Vitamin K 2.6E-06 
C05441 Vitamin D2 5.2E-06 
C05443 Vitamin D3 7.8E-06 
C05776 Vitamin B12 5.2E-07 
C06262 Phosphorus 0.104 
C06424 Myristic acid 2.574 
C06427 Linolenic acid 0.416 
C08362 Palmitoleic acid 1.04 
C16526 Eicosenoic acid 0.312 
C00078 Tryptophan 0.13 
C00188 Threonine 0.364 
C00407 Isoleucine 0.442 
C00123 Leucine 0.754 
C00047 Lysine 0.546 
C00073 Methionine 0.156 
C00097 Cysteine 0.156 
C00079 Phenylalanine 0.364 
C00082 Tyrosine 0.416 
C00183 Valine 0.494 
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C00062 Arginine 0.338 
C00135 Histidine 0.182 
C00041 Alanine 0.286 
C00049 Aspartic acid 0.65 
C00025 Glutamic acid 1.352 
C00037 Glycine 0.208 
C00148 Proline 0.65 
C00065 Serine 0.338 
 
 
Table 2: Complete metabolite set of Diet 2 (Mother’s Milk + Rice Cereal) 
Compounds Names Total 
C00041 Alanine 0.308 
C00219 Arachidonic acid 0.224 
C00062 Arginine 0.364 
C00049 Aspartic acid 0.7 
C00719 Betaine 0.09912 
C00120 Biotin 7.08E-06 
C00076 Calcium 0.291 
C01571 Capric acid 0.532 
C00698 Chloride 1.078 
C00187 Cholesterol 0.112 
C00114 Choline 0.1374 
C00070 Copper 0.000451 
C00097 Cysteine 0.168 
C16526 Eicosenoic acid 0.336 
C00504 Folate 0.000059 
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C00031 Glucose 0.03 
C00025 Glutamic acid 1.456 
C00037 Glycine 0.224 
C00135 Histidine 0.196 
C01382 Iodine 5.13E-05 
C00023 Iron 0.000945 
C00407 Isoleucine 0.476 
C00243 Lactose 59.36 
C02679 Lauric acid 2.212 
C00123 Leucine 0.812 
C01595  Linoleic acid 3.229 
C06427 Linolenic acid 0.449 
C00047 Lysine 0.588 
C00305 Magnesium 0.0285 
C00208 Maltose 0.025 
C00034 Manganese 0.000242 
C00073 Methionine 0.168 
C06424 Myristic acid 2.772 
C00253 Niacin 0.001828 
C00712 Oleic acid 12.717 
C00249 Palmitic acid 7.926 
C08362 Palmitoleic acid 1.12 
C00864 Pantothenic acid 0.001952 
C00079 Phenylalanine 0.392 
C06262 Phosphorus 0.1155 
C00238 Potassium 0.4515 
C00148 Proline 0.7 
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C00314 Pyridoxine 0.000095 
C00255 Riboflavin 0.000326 
C01529 Selenium 1.97E-05 
C00065 Serine 0.364 
C01330 Sodium 0.1405 
C01530 Stearic acid 2.5205 
C00089 Sucrose 0.005 
C00378 Thiamin(e) 0.000127 
C00188 Threonine 0.392 
C00078 Tryptophan 0.14 
C00082 Tyrosine 0.448 
C00183 Valine 0.532 
C00473 Vitamin A 0.001078 
C05776 Vitamin B12 6.2E-07 
C00072 Vitamin C 0.04205 
C05441 Vitamin D2 5.6E-06 
C05443 Vitamin D3 8.5E-06 
C02477 Vitamin E 0.00006 
C01628 Vitamin K 2.8E-06 
C00001 Water 754.665 
C00038 Zinc 0.001535 
C00317 Amylopectin 1.0286 
C00718 Amylose 0.3614 
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Table 3: Complete metabolite set of Diet 3 (Mother’s Milk + Rice Cereal + Formula + Peas) 
Compounds Names Total 
C00001 Water 1760.985 
C00023 Iron 0.004125 
C00025 Glutamic acid 1.502881 
C00031 Glucose 0.245968 
C00034 Manganese 0.00018 
C00037 Glycine 0.224128 
C00038 Zinc 0.002542 
C00041 Alanine 0.300678 
C00047 Lysine 0.573369 
C00049 Aspartic Acid 0.625048 
C00062 Arginine 0.336535 
C00065 Serine 0.356636 
C00070 Copper 0.000474 
C00072 Vitamin C 0.044402 
C00073 Methionine 0.169072 
C00076 Calcium 0.33692 
C00078 Tryptophan 0.142027 
C00079 Phenylalanine 0.408421 
C00082 Tyrosine 0.460421 
C00089 Sucrose 1.793331 
C00095 Fructose 0.138206 
C00097 Cysteine 0.181072 
C00718 Amylose 2.4219 
C00114 Choline 0.13624 
C00120 Biotin 2.99E-05 
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C00123 Leucine 0.778323 
C00124 Galactose 0.00179 
C00135 Histidine 0.180276 
C00137 Inositol 0.000459 
C00148 Proline 0.663926 
C00182 Valine 0.483794 
C00187 Cholesterol 0.096 
C00188 Threonine 0.383498 
C00208 Maltose 0.185244 
C00219 Arachidonic acid 0.20344 
C00238 Potassium 0.48974 
C00243 Lactose 55.17409 
C00249 Palmitic acid 7.31664 
C00253 Niacin 0.003622 
C00255 Riboflavin 0.000443 
C02679 Lauric acid 2.07816 
C00305 Magnesium 0.04002 
C00314 Pyridoxine 0.000185 
C00317 Amylopectin 6.8931 
C00378 Thiamin(e) 0.000259 
C00407 Isoleucine 0.447854 
C00473 Vitamin A 0.000967 
C00504 Folate 8.92E-05 
C00698 Chloride 0.948499 
C00712 Oleic acid 11.709 
C00719 Betaine 0.085066 
C00742 Fluoride 1.02E-05 
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C00864 Pantothenic acid 0.002151 
C01330 Sodium 0.16106 
C01382 Iodine 4.40E-05 
C01529 Selenium 1.82E-05 
C01530 Stearic acid 2.25498 
C01571 Capric acid 0.47888 
C01585 Caporic acid 0.00528 
C01595  Linoleic acid 3.304208 
C01628 Vitamin K 0.046006 
C02477 Vitamin E 0.001024 
C02483 gamma-Tocopherol 0.000337 
C05441 Vitamin D2 5.11E-06 
C05443 Vitamin D3 8.01E-06 
C05776 Vitamin B12 8.94E-07 
C06262 Phosphorus 0.16822 
C06423 Caprylic acid 0.03344 
C06424 Myristic acid 2.46048 
C06427 Linolenic acid 0.46244 
C08601 Lutein 0.001024 
C08316 Erucic acid 0.00528 
C08362 Palmitoleic acid 0.96528 
C16526 Eicosenoic acid 0.29328 
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Table 4: Complete metabolite set of Diet 3 (Cow’s Milk + Adult Diet) 
Compounds Names Total 
C09727 (-)-Epicatechin 0.0005 
C12136 (-)-Epigallocatechin 0.00087 
C06562 (+)-Catechin 0.102 
C00041 Alanine 1.237356 
C00317 Amylopectin 24.6639 
C00718 Amylose 23.902 
C01889 Arabinoxylan 0.1719 
C06425 Arachidic acid 0.0402 
C00219 Arachidonic acid 0.0598 
C00062 Arginine 1.341628 
C00049 Aspartic acid 2.726346 
C00965 Beta glucans 0.34825 
C01753 beta sitosterol 0.008206 
C00719 Betaine 0.0238 
C01753 Beta-sitosterol 0.001 
C00120 Biotin 2.29E-05 
C00246 Butyric acid 0.6716 
C00076 Calcium, Ca 0.319 
C01789 Campesterol 0.001919 
C01571 Capric acid  0.392 
C01585 Caproic acid 0.4042 
C06423 Caprylic acid  0.185 
C05433 Carotene, alpha 0.000001 
C02094 Carotene, beta 1.18E-04 
C00760 Cellulose 1.6541 
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C00698 Chloride 0.21056 
C00187 Cholesterol 0.17 
C00114 Choline 0.18411 
C16513 clupanodonic acid 0.001 
C05776 Cobalmin(III) 2.00E-08 
C00070 Copper, Cu 0.000927 
C08591 Cryptoxanthin, beta 1.13E-05 
C05905 Cyanidin 0.00087 
C00491 Cystine 0.428285 
C01571 Decanoic 0.3778 
C06429 Docosahexaenoic acid (DHA) 0.011 
C08281 docosanoic acid 0.117 
C16513 Docosapentaenoic  acid 0.003 
C08316  Docosenoic acid 0.984 
C16525 Eicosadienoic acid 0.003 
C06428 Eicosapentaenoic acid (EPA) 0.003 
C16522 Eicosatrienoic acid 0.006 
C16526 Eicosenoic acid 0.987 
C00742 Fluoride, F 5.51E-05 
C00504 Folate, total 2.32E-04 
C01355 Fructan 0.01365 
C00095 Fructose 6.414 
C00124 Galactose 0.8585 
C00333 Galacturnic acid 0.0074 
C06426 gamma-linolenic acid 0.004 
C06563 Genistein 0.01 
C00031 Glucose (dextrose) 6.838 
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C00025 Glutamic acid 4.046505 
C00037 Glycine 1.107421 
C15805 Guaiacyl lignin 0.0255 
C16536 Heptadecanoic acid 0.1444 
C00135 Histidine 0.593237 
C01157 Hydroxyproline 0.001 
C01382 Iodine 7.33E-05 
C00023 Iron, Fe 0.006218 
C08821 Isofucosterol 0.000505 
C00407 Isoleucine 1.098167 
C00243 Lactose 3.546 
C02679 Lauric acid 0.6624 
C00123 Leucine 1.927271 
C08320 Lignoceric acid  0.001 
C01595 Linoleic acid 4.7288 
C06427 Linolenic (alpha) acid 0.741 
C08601 Lutein + zeaxanthin 1.36E-04 
C00047 Lysine 1.572039 
C00305 Magnesium, Mg 0.089 
C00208 Maltose 0.32 
C00034 Manganese, Mn 0.016171 
C00159 Mannose 0.1015 
C00073 Methionine 0.425867 
C06424 Myristic acid 1.8354 
C06424 Myristoleic acid 0.0662 
C08323 nervonic acid 0.001 
C00253 Niacin 0.008448 
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C01530 Octadecadienoic acid 0.3872 
C06427 Octadecatrienoic acid 0.007 
C00712 Oleic acid 6.77 
C00249 Palmitic acid 7.0016 
C08362 Palmitoleic acid 0.8916 
C00864 Pantothenic acid 0.003907 
C00714 Pectin 0.0648 
C16537 Pentadecanoic 0.0976 
C00079 Phenylalanine 1.118356 
C06262 Phosphorus, P 0.5092 
C15804 p-hydroxyphenyl lignin 0.0255 
C00238 Potassium, K 0.6556 
C10237 Proanthocyanidin A2 (dimer) 0.3006 
C00148 Proline 1.440016 
C00389 Quercetin 0.00087 
C00492 Raffinose 0.12356 
C00507 Rhammose 0.216 
C00255 Riboflavin 0.002943 
C01529 Selenium, Se 6.86E-05 
C00065 Serine 1.050668 
C01330 Sodium, Na 0.71555 
C00794 Sorbitol 0.57 
C01613 Stachyose 0.3222 
C01530 Stearic acid 2.771 
C05442 Stigmasterol 0.001641 
C00089 Sucrose 9.5432 
C15806 Syringyl lignin 0.0255 
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C08320 Tetracosanoic acid 0.019 
C00378 Thiamin 0.00252 
C00188 Threonine 0.996535 
C06428 timnodonic acid 0.014 
C14152 Tocopherol, beta 0.00007 
C14151 Tocopherol, delta 0.00028 
C02483 Tocopherol, gamma 0.00301 
C00078 Tryptophan 0.316556 
C00082 Tyrosine 0.898684 
C00182 Valine 1.295393 
C08252 Verbascose 0.37 
C00473 Vitamin A, RAE 0.001814 
C05776 Vitamin B-12 34 
C00314 Vitamin B-6 (pyridoxine) 0.002621 
C00072 Vitamin C 0.00503 
C01673 Vitamin D 2.73E-05 
C05441 Vitamin D2 2.5E-07 
C05433 Vitamin D3 1.98E-06 
C02477 Vitamin E (alpha-tocopherol) 0.003474 
C01628 Vitamin K (phylloquinone) 1.00E-05 
C00001 Water 261.962 
C00181 Xylose 0.324 
C00038 Zinc, Zn 0.018892 
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Table 5: Breakup of complex molecules – Casein  
C00078 Tryptophan 
C00188 Threonine 
C00407 Isoleucine 
C00123 Leucine 
C00047 Lysine 
C00073 Methionine 
C00097 Cysteine 
C00079 Phenylalanine 
C00082 Tyrosine 
C00183 Valine 
C00062 Arginine 
C00135 Histidine 
C00041 Alanine 
C00049 Aspartic acid 
C00025 Glutamic acid 
C00037 Glycine 
C00148 Proline 
C00065 Serine 
 
 
 
Table 6: Seed set for metabolite abundance cut-off above -5 
 
Diet 1 Diet 2 Diet 3 Diet 4 
C00001 Water C00041 Alanine C00001 Water C09727 (-)-Epicatechin 
C00023 Iron C00219 Arachidonic 
acid 
C00023 Iron C12136 (-)-
Epigallocatechin 
C00034 Manganese C00062 Arginine C00025 Glutamic acid C06562 (+)-Catechin 
C00038 Zinc C00049 Aspartic acid C00031 Glucose C00041 Alanine 
C00070 Copper C00719 Betaine C00034 Manganese C00317 Amylopectin 
C00072 Vitamin C C00076 Calcium C00037 Glycine C00718 Amylose 
C00076 Calcium C01571 Capric acid C00038 Zinc C01889 Arabinoxylan 
C00114 Choline C00698 Chloride C00041 Alanine C06425 Arachidic acid 
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C00187 Cholesterol C00187 Cholesterol C00047 Lysine C00219 Arachidonic acid 
C00219 Arachidonic 
acid 
C00114 Choline C00049 Aspartic Acid C00062 Arginine 
C00238 Potassium C00070 Copper C00062 Arginine C00049 Aspartic acid 
C00243 Lactose C00097 Cysteine C00065 Serine C00965 Beta glucans 
C00249 Palmitic acid C16526 Eicosenoic 
acid 
C00070 Copper C01753 beta sitosterol 
C00253 Niacin C00504 Folate C00072 Vitamin C C00719 Betaine 
C00255 Riboflavin C00031 Glucose C00073 Methionine C01753 Beta-sitosterol 
C02679 Lauric acid C00025 Glutamic acid C00076 Calcium C00120 Biotin 
C00305 Magnesium C00037 Glycine C00078 Tryptophan C00246 Butyric acid 
C00314 Pyridoxine C00135 Histidine C00079 Phenylalanine C00076 Calcium, Ca 
C00378 Thiamin(e) C01382 Iodine C00082 Tyrosine C01789 Campesterol 
C00473 Vitamin A C00023 Iron C00089 Sucrose C01571 Capric acid  
C00504 Folate C00407 Isoleucine C00095 Fructose C01585 Caproic acid 
C00698 Chloride C00243 Lactose C00097 Cysteine C06423 Caprylic acid 
C00712 Oleic acid C02679 Lauric acid C00718 Amylose C02094 Carotene, beta 
C00719 Betaine C00123 Leucine C00114 Choline C00760 Cellulose 
C00864 Pantothenic 
acid 
C01595  Linoleic acid C00120 Biotin C00698 Chloride 
C01330 Sodium C06427 Linolenic acid C00123 Leucine C00187 Cholesterol 
C01382 Iodine C00047 Lysine C00124 Galactose C00114 Choline 
C01529 Selenium C00305 Magnesium C00135 Histidine C16513 clupanodonic acid 
C01530 Stearic acid C00208 Maltose C00137 Inositol C00070 Copper, Cu 
C01571 Capric acid C00034 Manganese C00148 Proline C08591 Cryptoxanthin, 
beta 
C01595  Linoleic acid C00073 Methionine C00182 Valine C05905 Cyanidin 
C06262 Phosphorus C06424 Myristic acid C00187 Cholesterol C00491 Cystine 
C06424 Myristic acid C00253 Niacin C00188 Threonine C01571 Decanoic 
C06427 Linolenic acid C00712 Oleic acid C00208 Maltose C06429 Docosahexaenoic 
acid (DHA) 
 55 
C08362 Palmitoleic 
acid 
C00249 Palmitic acid C00219 Arachidonic 
acid 
C08281 docosanoic acid 
C16526 Eicosenoic 
acid 
C08362 Palmitoleic 
acid 
C00238 Potassium C16513 Docosapentaenoic  
acid 
C00078 Tryptophan C00864 Pantothenic 
acid 
C00243 Lactose C08316 Docosenoic acid 
C00188 Threonine C00079 Phenylalanine C00249 Palmitic acid C16525 Eicosadienoic 
acid 
C00407 Isoleucine C06262 Phosphorus C00253 Niacin C06428 Eicosapentaenoic 
acid (EPA) 
C00123 Leucine C00238 Potassium C00255 Riboflavin C16522 Eicosatrienoic 
acid 
C00047 Lysine C00148 Proline C02679 Lauric acid C16526 Eicosenoic acid 
C00073 Methionine C00314 Pyridoxine C00305 Magnesium C00742 Fluoride, F 
C00097 Cysteine C00255 Riboflavin C00314 Pyridoxine C00504 Folate, total 
C00079 Phenylalanine C01529 Selenium C00317 Amylopectin C01355 Fructan 
C00082 Tyrosine C00065 Serine C00378 Thiamin(e) C00095 Fructose 
C00183 Valine C01330 Sodium C00407 Isoleucine C00124 Galactose 
C00062 Arginine C01530 Stearic acid C00473 Vitamin A C00333 Galacturnic acid 
C00135 Histidine C00089 Sucrose C00504 Folate C06426 gamma-linolenic 
acid 
C00041 Alanine C00378 Thiamin(e) C00698 Chloride C06563 Genistein 
C00049 Aspartic acid C00188 Threonine C00712 Oleic acid C00031 Glucose 
(dextrose) 
C00025 Glutamic acid C00078 Tryptophan C00719 Betaine C00025 Glutamic acid 
C00037 Glycine C00082 Tyrosine C00742 Fluoride C00037 Glycine 
C00148 Proline C00183 Valine C00864 Pantothenic 
acid 
C15805 Guaiacyl lignin 
C00065 Serine C00473 Vitamin A C01330 Sodium C16536 Heptadecanoic 
acid 
 -  - C00072 Vitamin C C01382 Iodine C00135 Histidine 
 -  - C02477 Vitamin E C01529 Selenium C01157 Hydroxyproline 
 -  - C00001 Water C01530 Stearic acid C01382 Iodine 
 -  - C00038 Zinc C01571 Capric acid C00023 Iron, Fe 
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 -  - C00317 Amylopectin C01585 Caporic acid C08821 Isofucosterol 
 -  - C00718 Amylose C01595  Linoleic acid C00407 Isoleucine 
 -  -  -  - C01628 Vitamin K C00243 Lactose 
 -  -  -  - C02477 Vitamin E C02679 Lauric acid 
 -  -  -  - C02483 gamma-
Tocopherol 
C00123 Leucine 
 -  -  -  - C06262 Phosphorus C08320 Lignoceric acid  
 -  -  -  - C06423 Caprylic acid C01595 Linoleic acid 
 -  -  -  - C06424 Myristic acid C06427 Linolenic (alpha) 
acid 
 -  -  -  - C06427 Linolenic acid C08601 Lutein + 
zeaxanthin 
 -  -  -  - C08601 Lutein C00047 Lysine 
 -  -  -  - C08316 Erucic acid C00305 Magnesium, Mg 
 -  -  -  - C08362 Palmitoleic 
acid 
C00208 Maltose 
 -  -  -  - C16526 Eicosenoic 
acid 
C00034 Manganese, Mn 
 -  -  -  -  -  - C00159 Mannose 
 -  -  -  -  -  - C00073 Methionine 
 -  -  -  -  -  - C06424 Myristic acid 
 -  -  -  -  -  - C06424 Myristoleic acid 
 -  -  -  -  -  - C08323 nervonic acid 
 -  -  -  -  -  - C00253 Niacin 
 -  -  -  -  -  - C01530 Octadecadienoic 
acid 
 -  -  -  -  -  - C06427 Octadecatrienoic 
acid 
 -  -  -  -  -  - C00712 Oleic acid 
 -  -  -  -  -  - C00249 Palmitic acid 
 -  -  -  -  -  - C08362 Palmitoleic acid 
 -  -  -  -  -  - C00864 Pantothenic acid 
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 -  -  -  -  -  - C00714 Pectin 
 -  -  -  -  -  - C16537 Pentadecanoic 
 -  -  -  -  -  - C00079 Phenylalanine 
 -  -  -  -  -  - C06262 Phosphorus, P 
 -  -  -  -  -  - C15804 p-hydroxyphenyl 
lignin 
 -  -  -  -  -  - C00238 Potassium, K 
 -  -  -  -  -  - C10237 Proanthocyanidin 
A2 (dimer) 
 -  -  -  -  -  - C00148 Proline 
 -  -  -  -  -  - C00389 Quercetin 
 -  -  -  -  -  - C00492 Raffinose 
 -  -  -  -  -  - C00507 Rhammose 
 -  -  -  -  -  - C00255 Riboflavin 
 -  -  -  -  -  - C01529 Selenium, Se 
 -  -  -  -  -  - C00065 Serine 
 -  -  -  -  -  - C01330 Sodium, Na 
 -  -  -  -  -  - C00794 Sorbitol 
 -  -  -  -  -  - C01613 Stachyose 
 -  -  -  -  -  - C01530 Stearic acid 
 -  -  -  -  -  - C05442 Stigmasterol 
 -  -  -  -  -  - C00089 Sucrose 
 -  -  -  -  -  - C15806 Syringyl lignin 
 -  -  -  -  -  - C08320 Tetracosanoic 
acid 
 -  -  -  -  -  - C00378 Thiamin 
 -  -  -  -  -  - C00188 Threonine 
 -  -  -  -  -  - C06428 timnodonic acid 
 -  -  -  -  -  - C14152 Tocopherol, beta 
 -  -  -  -  -  - C14151 Tocopherol, delta 
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 -  -  -  -  -  - C02483 Tocopherol, 
gamma 
 -  -  -  -  -  - C00078 Tryptophan 
 -  -  -  -  -  - C00082 Tyrosine 
 -  -  -  -  -  - C00182 Valine 
 -  -  -  -  -  - C08252 Verbascose 
 -  -  -  -  -  - C00473 Vitamin A, RAE 
 -  -  -  -  -  - C05776 Vitamin B-12 
 -  -  -  -  -  - C00314 Vitamin B-6 
(pyridoxine) 
 -  -  -  -  -  - C00072 Vitamin C 
 -  -  -  -  -  - C01673 Vitamin D 
 -  -  -  -  -  - C02477 Vitamin E (alpha-
tocopherol) 
 -  -  -  -  -  - C00001 Water 
 -  -  -  -  -  - C00181 Xylose 
 -  -  -  -  -  - C00038 Zinc, Zn 
 
 
                                        Table 7: Seed set for metabolite abundance cut-off above 𝟎 
 
Diet 1 Diet 2 Diet 3 Diet 4 
C00001 Water C00698 Chloride C00001 Water C00041 Alanine 
C00243 Lactose C00025 Glutamic acid C00025 Glutamic acid C00317 Amylopectin 
C00249 Palmitic 
acid 
C00243 Lactose C00089 Sucrose C00718 Amylose 
C02679 Lauric acid C02679 Lauric acid C00718 Amylose C00062 Arginine 
C00698 Chloride C01595  Linoleic acid C00243 Lactose C00049 Aspartic acid 
C00712 Oleic acid C06424 Myristic acid C00249 Palmitic acid C00760 Cellulose 
C01530 Stearic acid C00712 Oleic acid C02679 Lauric acid C00095 Fructose 
C01595  Linoleic 
acid 
C00249 Palmitic acid C00317 Amylopectin C00031 Glucose 
(dextrose) 
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C06424 Myristic 
acid 
C08362 Palmitoleic acid C00712 Oleic acid C00025 Glutamic acid 
C08362 Palmitoleic 
acid 
C01530 Stearic acid C01530 Stearic acid C00037 Glycine 
C00025 Glutamic 
acid 
C00001 Water C01595  Linoleic acid C00407 Isoleucine 
 -  - C00317 Amylopectin C06424 Myristic acid C00243 Lactose 
 -  -  -  -  -  - C00123 Leucine 
 -  -  -  -  -  - C01595 Linoleic acid 
 -  -  -  -  -  - C00047 Lysine 
 -  -  -  -  -  - C06424 Myristic acid 
 -  -  -  -  -  - C00712 Oleic acid 
 -  -  -  -  -  - C00249 Palmitic acid 
 -  -  -  -  -  - C00079 Phenylalanine 
 -  -  -  -  -  - C00148 Proline 
 -  -  -  -  -  - C00065 Serine 
 -  -  -  -  -  - C01530 Stearic acid 
 -  -  -  -  -  - C00089 Sucrose 
 -  -  -  -  -  - C00182 Valine 
 -  -  -  -  -  - C05776 Vitamin B-12 
 -  -  -  -  -  - C00001 Water 
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Figure 1: Network Size v/s the cut-offs. The orange lines indicate the points used for case study 
 
 
 
 
 
 
 
 
 
 
 
Table 8:  Reactions added to the network with different diets for log abundance  
threshold of metabolites above -5 
 
Cut-off diet 1 - diet 2 diet 2 - diet 3 diet 3 - diet 4 
-5 2.1.1.95 2.5.1.63 1.1.1.219 
 2.1.1.295 3.5.1.12 1.3.1.77 
 2.5.1.115 6.2.1.11 1.3.99.27 
 2.5.1.116 6.3.4.9 1.17.1.3 
 2.5.1.117 6.3.4.10 2.1.7.6 
 5.5.1.24 6.3.4.11 2.1.1.82 
  - 6.3.4.15 2.1.1.83 
  -  - 2.1.1.210 
  -  - 2.3.1.116 
  -  - 2.3.1.153 
  -  - 2.3.1.171 
  -  - 2.3.1.172 
  -  - 2.3.1.215 
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  -  - 2.4.1.91 
  -  - 2.4.1.115 
  -  - 2.4.1.116 
  -  - 2.4.1.159 
  -  - 2.4.1.237 
  -  - 2.4.1.238 
  -  - 2.4.1.239 
  -  - 2.4.1.240 
  -  - 2.4.1.249 
  -  - 2.4.1.254 
  -  - 2.4.1.294 
  -  - 2.4.1.295 
  -  - 2.4.1.297 
  -  - 2.4.1.298 
  -  - 2.4.2.35 
  -  - 2.4.2.50 
  -  - 2.4.2.51 
  -  - 2.8.2.25 
  -  - 2.8.2.26 
  -  - 2.8.2.27 
  -  - 2.8.2.28 
  -  - 3.2.1.66 
  -  - 4.2.1.131 
  -  - 5.2.1.5 
  -  - 5.2.1.13 
  -  - 5.2.1.14 
  -  - 5.3.3.13 
  -  - 5.5.1.18 
  -  - 5.5.1.19 
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Table 9: Reactions added to the network with different diets for log abundance 
threshold of metabolites above 0 
 
 
 
 
 
 
 
 
 
 
 
                               Table 10: Reactions added to the network with different diets for all metabolites  
  
 
Cut-off diet 1 - diet 2 diet 2 - diet 3 diet 3 - diet 4 
all 2.1.1.95 2.5.1.63 1.1.1.219 
 2.1.1.295  - 1.3.1.77 
 2.5.1.115  - 1.3.99.27 
 2.5.1.116  - 1.17.1.3 
 2.5.1.117  - 2.1.7.6 
 5.5.1.24  - 2.1.1.82 
  -  - 2.1.1.83 
  -  - 2.1.1.210 
  -  - 2.3.1.116 
  -  - 2.3.1.153 
  -  - 2.3.1.171 
  -  - 2.3.1.172 
  -  - 2.3.1.215 
  -  - 2.4.1.91 
  -  - 2.4.1.115 
  -  - 2.4.1.116 
  -  - 2.4.1.159 
  -  - 2.4.1.237 
Cut-off diet 1 - diet 2 diet 2 - diet 3 diet 3 - diet 4 
0  - 1.11.2.2 5.2.1.5 
  - 2.5.1.94  -  
  - 3.8.1.16  -  
  - 3.8.1.17  -  
  - 4.5.1.4  -  
  - 5.2.1.10  -  
  - 6.2.1.33  -  
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  -  - 2.4.1.238 
  -  - 2.4.1.239 
  -  - 2.4.1.240 
  -  - 2.4.1.249 
  -  - 2.4.1.254 
  -  - 2.4.1.294 
  -  - 2.4.1.295 
  -  - 2.4.1.297 
  -  - 2.4.1.298 
  -  - 2.4.2.35 
  -  - 2.4.2.50 
  -  - 2.4.2.51 
  -  - 2.8.2.25 
  -  - 2.8.2.26 
  -  - 2.8.2.27 
  -  - 2.8.2.28 
  -  - 3.2.1.66 
  -  - 4.2.1.131 
  -  - 5.2.1.5 
  -  - 5.2.1.13 
  -  - 5.2.1.14 
  -  - 5.3.3.13 
  -  - 5.5.1.18 
  -  - 5.5.1.19 
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CHAPTER THREE 
Identifying dysregulated metabolic pathways associated with gastric cancer and the 
effect of H. pylori on tumor pathways 
 
3.1 Background 
 
Gastric cancer originates from the stomach mucosa and is the fourth most 
common cause of cancer-related death in the world. It remains difficult to cure in 
Western countries, primarily because most patients present with advanced disease 79. 
Factors of stomach or gastric cancer can be adenomatous gastric polyps larger than two 
centimeters, chronic atrophic gastritis, or pernicious anemia. Smoking and consumption 
of salted, cured or smoked foods can also exacerbate the condition. A genetic component 
to the cancer is present in approximately 10% of cases and it is mostly found to occur in 
men over the age of 40. This cancer is most prevalent in Japan, Chile, and Iceland. The 
diagnosis is done from a biopsy of tissue obtained from gastroscopy. In this procedure, a 
fiber optic camera is inserted into the stomach via the esophagus and then mucosal 
samples are scooped or sampled.  
Adenocarcinoma is the most common type of stomach cancer.  From the 
histologic point of view there are two main types of adenocarcinoma: intestinal and 
diffuse. The intestinal subtype is composed of irregular glands that have a "back-to-back" 
appearance whereas the diffuse subtype is composed of loosely cohesive cells which 
secrete mucus into the interstitium. Apart from that the intestinal type seems to be more 
age dependent compared to the diffuse type 80. 
Cancer stage is classified according to the TNM system. This system describes 
the growth of the primary tumor (T), its spread to nearby lymph nodes (N) and the 
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absence or presence of distant spread known as metastasis (M). In Stage 0, the cancer is 
just on the inner lining of the stomach. This stomach cancer is treatable in the early stages 
by endoscopic mucosal resection, or by gastrectomy and lymphadenectomy without a 
resorting to chemotherapy or radiation. During Stage I the tumor penetrates to the second 
or third layers of the stomach (IA) or to the nearby lymph nodes (IB). Stage IA is treated 
by surgery whereas for Stage IB chemotherapy maybe needed. In Stage II, apart from 
penetrating into the mucosal layers the tumor also spreads to the more distant lymph 
nodes. The treatment for this is the same as Stage I. Stage III is characterized by 
beginning of metastasis penetration and by Stage IV the tumor as completely 
metastasized to distant organs. A cure is very rarely possible at this stages III or IV. The 
survival rate for each stage of gastric  
cancer is highlighted in Table 1. 
 
 
 
 
 
 
 
 
 
 
Stage 5 year observed survival 
Stage IA 71% 
Stage IB 57% 
Stage IIA 46% 
Stage IIB 33% 
Stage IIIA 20% 
Stage IIIB 14% 
Stage IIIC 9% 
Stage IV 4% 
Table 1: Table showing the 5-year survival rates by stage for stomach/gastric cancer treated with 
surgery. [Cancer.gov] 
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Spontaneous occurrence of gastric cancer is extremely rare 81. However, an 
important development in the epidemiology of gastric carcinoma has been the recognition 
of the association with Helicobacter pylori. H. pylori is a spiral shaped gram negative 
bacterium that has the ability to grow on gastric epithelial tissue. It grows in the acidic 
environment of the stomach and converts urea to ammonia creating a viable basic or 
neutral environment for it to grow 82. It is found freely in nature and spreads due to 
contaminated food and water. It is a threat in more developing countries. Signs of 
infection include feeling bloated, nausea, vomiting, lack of appetite, anorexia and/or 
unexplained weight loss. Diagnosis is generally by a blood tests that searches for 
antibodies against H. pylori. Some strains have the ability to invade the host cell better 
due to the presence of “Pathogenicity Islands” (PAIs) resulting in greater persistence 83. 
These “islands” are a cluster of approximately 30 genes which can cause activation of 
transcription factor NF- B in gastric epithelial cells and are also associated with encoding 
a type IV secretion 84. This means that the microbe has the ability to transport virulence 
proteins right into the host cells. Apart from this the genes can also increase the activity 
of interleukin-8 (IL-8). IL-8 is the major chemokine causes upregulation of neutrophils to 
the infection site; thus, increasing inflammation. Due to all these reasons, in 1994, the 
International Agency for Research on Cancer classified H. pylori as a carcinogen 
depending on its virulence level. 
H. pylori is believed to be present in approximately two-thirds of the world’s population. 
It causes more intestinal adenocarcinoma than the diffuse type 85. However even among 
infected individuals the susceptibility to cancer is significantly lower. Approximately 
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10% develop peptic ulcer disease and from there only 1% to 3% develop gastric 
adenocarcinoma 23.  While the increased chance of gastric cancer for individuals with 
active H. pylori infection has been documented, much remains to be understood about the 
connection between host-microbe interaction and the onset of gastric cancer.  
3.2 Methods 
3.2.1 Data 
 
Published data from the GEO 86 (Gene Expression Omnibus) database was used. The first 
was an Agilent gene expression microarray data for patients affected with gastric cancer - 
GSE33428 87. Cancer is heterogeneous i.e. every person’s tumor has a unique growth 
pattern. In order to reduce this, I selected the same patients for tumor and normal 
comparison i.e. the normal sample was collected from the adjoining uninfected gastric 
tissue. This cohort consisted of 27 patients with no information about the ethnicity. The 
ages ranged from 41- 84 years. A breakdown of the samples can be seen in Table 2 along 
with the pipeline for analysis in Figure 1. 
 
Sample Type     No. of Samples No. of Samples used 
Gastric cancer tissue  27 27 
Gastric non-cancer tissue  27 27 
 
 
 
 
Table 2: Details of dataset1 (GSE33428) used 
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The second was an Affymetrix cell line microarray expression which was 
specifically derived from gastric cancer adenocarcinoma, the AGS cell line. This cell 
line was infected with different strains of H. Pylori namely high pathogenic and low 
pathogenic strains - GSE27347. This dataset was chosen as it could predict the 
difference between the pathogenic and non-pathogenic strains of H. pylori as mentioned 
above in the chapter introduction. The control used in this case was an un-infected cell 
line. The experiment was done in triplicates for each strain and control. This 
information is represented in Table 3 and Figure 2. 
 
Samples  
Strain A (high 
pathogenicity)  
Strain B (low 
pathogenicity)  
Control 
Replicate A  A1 - GSM676126  A2 - GSM676129 A3 - GSM676132 
Replicate B  B1 - GSM676127 B2 - GSM676130 B3 - GSM676133 
Replicate C  C1 - GSM676128 C2 - GSM676131 C3 - GSM676134 
 
 
Differential 
Expression 
Analysis 
P-value < 0.05 
Z-score > 0 
Figure 1: Pipeline for analysis of GSE33428  
Table 3: Details of the GSE27347 dataset of AGS cell lines infected with different strains of H. 
pylori and control 
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3.2.2 Pre-processing 
 
Dataset one was normalized using the standard RMA suite normalization for 
microarrays 88. Following this, a differential analysis was done between tumor and 
normal samples 89 90. I was only interested in the metabolic changes occurring in cancer. 
So I looked at the genes that mapped to metabolic pathways in KEGG 91 6. The rationale 
for looking at metabolic changes is because these changes are universal in all cancers 
compared to signaling mechanisms. Also, changing this fundamental pathway provides 
nutrition to the cancer cells. Recently, microbes have been implicated to have effect on 
the metabolic pathways too by hijacking them for reproduction. I wanted to see if H. 
pylori has a similar effect that could affect gastric cancer and metastasis.  
This reduced the number of probes in the mRNA expression set. P-value of less 
than 0.05 and a Z-score of greater than 0 was considered as a threshold for significance of 
the probes. The probes were then mapped to the genes and this produced 156 up-
regulated metabolic genes. There were down-regulated genes belonging to metabolic 
pathway, but they did not fall into the significance category. Pathway enrichment was 
Figure 2: Cartoon example of Table 3 dataset 
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done using a hypergeometric test 92. Around 51 metabolic pathways are enriched as 
highlighted in Figure 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Metabolic pathway enrichments in gastric cancer on comparing tumor and normal 
samples where the green highlighted pathway shows mRNA dysregulations could involve 
pathways that can mediate interaction with H. pylori 
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The ones that are highlighted in red are the ones were more than 30% of the genes 
in the pathways was unregulated. These were mainly pathways that contribute to amino 
acid and glucose metabolism 93. This is because the cancer cells utilize the tricarboxylic 
acid (TCA) cycle to generate energy that is required to feed cancer cells and for fatty acid 
and phospholipid biosynthesis. Apart from this, another interesting observation was the 
enrichment in the H. pylori signaling pathway for patients who had no occurrence of the 
microbe. This lead to the first hypothesis that mRNA dysregulations could involve 
pathways that can mediate interaction with H. pylori [Epithelial cell signaling in 
Helicobacter pylori infection – hsa05120 in KEGG].   
In order to substantiate the above hypothesis and determine the causal effect of the 
microbe in gastric cancer the second dataset was used. The normalization protocol was 
the same as above. However, with traditional differential expression analysis for 
comparison between the abnormal samples and the control/normal, thresholds are then 
used to test significance. The thresholds used are usually p-values or fold changes. In 
most cases, more than log 2-fold change and p-values of about 0.05 are the usual cut-offs 
used. However, the drawback with this method is that if there are two abnormal states, 
though it can capture the total change between them it cannot provide any information as 
to where the changes came from. So instead of doing a conventional differential 
expression, I used a new method called the signal-to-noise method. As the name suggests 
this involves two metrics called ‘signal and ‘noise’. Signal is defined as the difference in 
gene expression between infected and uninfected sample. Noise is the difference in gene 
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expression between the uninfected samples. Mathematical representations of the Signal – 
to – noise-method is highlighted below. 
𝑍(𝑖) =  ∑|𝑥(𝑖, 𝑗) − 𝑥(𝑖, 𝑗′)|
𝑗,𝑗′
 
x = expression value in control for probe i, replicate j 
i = 1:2511 
j = 1:3 
𝑊(𝑖) =  ∑|𝑦(𝑖, 𝑗) − 𝑥(𝑖, 𝑗′)|
𝑗,𝑗′
 
x = expression value in control for probe i, replicate j 
y =  expression value in strains for probe i, replicate j  
i = 1:2511 
j = 1:3 
 
Z = Noise in the data 
W = Actual signal 
 
Noise(Z)
Signal(W)
= < 20% (i. e. more signal) 
 
3.3 Results 
 
The above new analysis is done by averaging cross all triplicates. The signal-noise 
method is not only able to capture strain specific differences between high and low 
pathogenic AGS cell line infected with H. pylori but also find the total difference from 
the control cell line. In other words, it can probe the differences between samples infected 
with different strains and also tell us which sample it came from. This is clearly 
demonstrated in Figure 4 and 5. Also performance wise, the new method can detect more 
dysregulated probes between the samples than the conventional method. As further proof, 
 73 
I analyzed the data with the new metric as well as the old differential expression pipeline. 
Comparing the two methods, my analysis with new metric produced 178 probes that are 
significant in the high pathogenic strain and 63 probes for the low pathogenic strain. 
Mapping these probes using the NCBI database produced 39 and 12 genes respectively 
for high and low pathogenic H. pylori. This brings the total to 52 genes. On the other 
hand, the traditional method involving volcano plots seen in Figure 6 only listed 26 
differentially expressed probes that corresponds to only 4 genes. This is further 
demonstrated in Table 4. 
 
 
 
 
 
 
 
  Conventional Differential Expression Signal-Noise Method 
Number of probes 26 178 – high pathogenic strain 
63 – low pathogenic strain 
Total genes 4 52 
Table 4: Performance of the Signal-Noise Method compared to Traditional Differential Expression 
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A heatmap representation of the samples clearly show that the high pathogenic H. 
pylori have a set of genes that are completely up-regulated when compared to low 
pathogenic strains and control as seen in Figure 7 and Table 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The next step involved performing a T-Test to identify significant probes between 
a particular strain and the control. This was done in order to find processes that might be 
different between high and low pathogenic strains of H. pylori providing a better insight 
GENE LIST 
ABCF1 CHPF GALNT2 NCSTN SMC3 
ACVR2B CHST14 GALNT3 NDST1 SMNDC1 
ANAPC5 CHST3 GALNT4 NEU1 SRP14 
APH1A COG1 GDI2 NONO ST6GAL1 
ARF1 COG4 GNPNAT1 NOTCH1 STARD7 
ASAH1 COG6 HINT1 NPL STS 
ATP6V0B COL9A2 HNRPM PAPSS2 TAF10 
B3GALT6 DGCR2 HPSE2 PARK7 TARDBP 
B3GNT5 DLL3 HS2ST1 PODXL2 TCEB2 
B4GALT7 DPM1 HS3ST1 POLR2I TPST1 
BMP4 DULLARD HSP90AB1 PSEN2 TPST2 
BMP7 EEF2 IGF2R PSMB2 UGP2 
C1GALT1C1 EIF3D IL6ST RFNG ZNF347 
C1orf103 ERH JAG2 RPL24 
 
C2orf24 FAU JTB RPL6 
 
CANX FNTA JUND RPS11 
 
CCL22 GAL3ST2 KARS SEP2  
 
CCL5 GALNT10 KLRF1 SGSH 
 
CFL1 GALNT14 LGALS12 SLC35B2 
 
Table 5: List of 89 genes that are dysregulated between high pathogenic vs low pathogenic and control  
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into mechanistic behavior of the microbes that might explain its interaction with gastric 
cancer. GO Term enrichment with clustering with average linkage shows that the high 
pathogenic H. pylori strains have a greater impact or enrichment for metabolic genes (p- 
value < 0.05) than they low pathogenic counterpart seen in Figure 8. This provides an 
idea as to how the high pathogenic strains of the bacteria can be virulent and cause more 
malignancy. That means the high pathogenic microbe might allow the cancer cells to 
hijack the metabolic pathways that can cause a decrease in healthy cells and progression 
and differentiation of tumor cells. To prove the hypothesis further and establish 
metabolic pathways that the high pathogenic H. pylori can regulate for tumorogenictiy; 
pathway enrichment was done using GSEA 94. The pathway enrichments are in Figure 
9.  
A closer look at the pathway enrichments of the two strains we see classic cancer 
signaling pathways dysregulated. These would include the Jak-STAT pathway, 
Cytokine Receptor pathway, VEGF and mTOR Signaling. For example, the activation 
of VEGF causes neovascularization, facilitating in production of more cancer cells 95. 
However, apart from that I noticed enrichment in the purine metabolism pathway in the 
high pathogenic strain. It has been recently known that purinergic signaling plays an 
important part in inflammation and cancer 96. This further proves that the high 
pathogenic H. pylori can exacerbate the cancer compared to the low pathogenic strain. 
The mechanism of inflammation is that this causes the release of ATP which is a part of 
the signaling process. The ATP has 2 receptors P2X and P2Y. There are seven P2X 
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receptors and eight P2Y receptors 97. The P2Y receptor is the one that is most affected 
by cancer.  
Out of the eight subtypes of P2Y, five purinoceptors have a greater effect on 
cancer by affecting several key processes.  P2Y1 and P2Y2 receptors might affect the 
rate of cell proliferation. P2X5 and P2Y11 receptor activation might causes changes in 
cell cycle and the P2X7 receptor activates the apoptosis. It is known in gastric cancer; 
that apoptosis could be mediated with ATP and adenosine 98 and Helicobacter pylori 
could contribute to the progression of gastric carcinoma, perhaps by regulation of H,K-
ATPase 99. However, more work would need to be done to show the association of the 
microbe with a particular purine receptor. 
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Figure 4: Calculating differences in the high pathogenic samples compared to Control  
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Figure 5: Calculating differences in the low pathogenic samples compared to Control  
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Figure 6: Volcano Plot for genes that are differentially expressed between strains and control 
Figure 7: Heatmap of different strains shows dysregulation of 89 genes between high pathogenic vs low 
pathogenic and control 
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Figure 8: (A) Go Term enrichment in the high pathogenic strains 
(B) Go Term enrichment in the low pathogenic strains; 
where the metabolic pathways are colored in red 
Figure 9: Pathway enrichment with GSEA 
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3.4 Discussion  
 
Thus in this chapter I have tried to elucidate the mechanism of association of the 
gram negative bacteria H. pylori to gastric cancer. Novel ways of analyzing differential 
gene expression made it clear that different strains of the microbe affect the cancer in 
different ways. This also further validates the claim as to how many people who have the 
microbe remain asymptomatic to it depending on the microbe type.  
Virulent strains of the bacteria have a greater effect on metabolic pathways than 
the less virulent strains. This makes the former strains more tumorigenic. Pathway 
analysis provides a possible method of how the metabolic dysregulations of the high 
pathogenic strain can cause metastasis and affect the host. One such pathway that is 
affected in the high pathogenic and virulent strains is purine metabolism. As mentioned 
above, this pathway has a direct association with inflammation and P2Y receptors. 
Several researches into this pathway and its receptors have shown that many of these are 
implicated with cancer. Thus, this sort of analysis provides us with a better understanding 
of different H. pylori bugs and methods to treat them. 
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CHAPTER FOUR: General Conclusions and Future Directions 
 
In this thesis, I have used high throughput 16S sequencing and microarray data to 
predict how microbes interact with the environment. The results from the chapters prove 
that: 
 For the order of colonization and context of enzymes the microbes in different stages 
strongly depend on the microbes in the previous step.  
 The diet plays an important part in determining the organisms and their diversity. Using 
network expansion approaches I can predict the organisms that would best represent the 
diet profile. 
 On a microscale, looking at the interaction of H. pylori and gastric cancer, I can also 
conclude that mRNA dysregulations in the human host can mediate interactions with the 
microbe. Also, I see that based on reviewed literature not all strains of the bacteria affect 
gastric cancer. On comparison of the bacteria with different strains and pathogenicity 
levels the highly pathogenic ones have a greater effect on the gastric cells by severely 
affecting inflammation pathways.  
 
However, as mentioned before, there are several methods that can be pursued to 
improve the results. The first method would be to test the microbiome pipeline and 
hypothesis for a larger sample size for microbiome data. The second method is to 
improve the network expansion by  leveraging genome scale metabolic models 100. These 
models have information about the enzyme stoichiometry of the organisms. Apart from 
that, it contains the biomass reaction which states the necessary components for growth 
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of the organism. This biomass reaction could be used to curate the amounts of the 
different diets used as input for the network expansion. A vast number of manually 
curated gut microbiome metabolic reconstructions were recently published 101. These 
would be a good source for thresholding the input diet metabolites.  
Lastly experiments could be set up where we can verify the network expansion 
algorithm and also the H. pylori hypothesis. For the former, in vivo experiments can be 
devised where the germ-free mice are fed different amounts of the diet and we can 
measure the different amounts of compounds produced by them, for instance short chain 
fatty acids, and then correlate these compounds back to the organisms that produced them 
in the diet. This way the changing amounts of diets could predict which organisms are the 
top drivers of metabolism in the diet. As for the H. pylori and the hypothesis that 
inflammation can be acerbated by the bacteria by upregulation of purine metabolism; 
gene knockout experiments can be done. The genes in the pathway can be knocked out to 
see how that affects the tumor cell and progression. 
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